Accumulated other comprehensive income (loss)

3 Months Ended

Mar. 31, 2021

Accumulated other comprehensive income (loss)

NOTE 14 – Accumulated other comprehensive income (loss):

The components of, and changes within, accumulated other comprehensive income (loss) attributable to Teva are presented in the table below:

	Net Unrealized Gains (Losses)						Benefit Plans
	Foreign currency translation adjustments			Derivative financial instruments			Actuarial gains (losses) and prior service (costs) credits			Total
	(U.S. $ in millions)
Balance as of December 31, 2020, net of taxes	$	(1,919	)	$	(363	)	$	(117	)	$	(2,399	)
Other comprehensive income (loss) before reclassifications		(174	)		—			—			(174	)
Amounts reclassified to the statements of income		—			9						9
Net other comprehensive income (loss) before tax		(174	)		9			—			(165	)
Corresponding income tax		33			(2	)		—			31
Net other comprehensive income (loss) after tax*		(141	)		7			—			(134	)
Balance as of March 31, 2021, net of taxes	$	(2,060	)	$	(356	)	$	(117	)	$	(2,534	)

* Amounts do not include a $67 million  loss from foreign currency  translation adjustments attributable to non-controlling interests.

	Net Unrealized Gains (Losses)						Benefit Plans
	Foreign currency translation adjustments			Derivative financial instruments			Actuarial gains (losses) and prior service (costs) credits			Total
	(U.S. $ in millions)
Balance as of December 31, 2019, net of taxes	$	(1,794	)	$	(420	)	$	(98	)	$	(2,312	)
Other comprehensive income (loss) before reclassifications		(573	)		22			—			(551	)
Amounts reclassified to the statements of income		—			8			—			8
Net other comprehensive income (loss) before tax		(573	)		30			—			(543	)
Corresponding income tax		3			—			—			3
Net other comprehensive income (loss) after tax*		(570	)		30			—			(540	)
Balance as of March 31, 2020, net of taxes	$	(2,364	)	$	(390	)	$	(98	)	$	(2,852	)

* Amounts do not include a $10 million loss from foreign currency translation adjustments attributable to non-controlling interests.